QLI vs. DRRX, ITRM, SLGL, EYEN, FBRX, LPCN, ACST, VAXX, UBX, and SNSE
Should you be buying Qilian International Holding Group stock or one of its competitors? The main competitors of Qilian International Holding Group include DURECT (DRRX), Iterum Therapeutics (ITRM), Sol-Gel Technologies (SLGL), Eyenovia (EYEN), Forte Biosciences (FBRX), Lipocine (LPCN), Acasti Pharma (ACST), Vaxxinity (VAXX), Unity Biotechnology (UBX), and Sensei Biotherapeutics (SNSE). These companies are all part of the "pharmaceutical preparations" industry.
DURECT (NASDAQ:DRRX) and Qilian International Holding Group (NASDAQ:QLI) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, earnings, valuation, dividends, community ranking, media sentiment, risk, profitability and institutional ownership.
DURECT currently has a consensus price target of $27.50, suggesting a potential upside of 2,902.51%. Given Qilian International Holding Group's higher possible upside, analysts plainly believe DURECT is more favorable than Qilian International Holding Group.
Qilian International Holding Group has a net margin of 0.00% compared to Qilian International Holding Group's net margin of -323.16%. DURECT's return on equity of 0.00% beat Qilian International Holding Group's return on equity.
DURECT has a beta of 0.85, indicating that its stock price is 15% less volatile than the S&P 500. Comparatively, Qilian International Holding Group has a beta of 1.5, indicating that its stock price is 50% more volatile than the S&P 500.
DURECT received 315 more outperform votes than Qilian International Holding Group when rated by MarketBeat users. However, 100.00% of users gave Qilian International Holding Group an outperform vote while only 65.83% of users gave DURECT an outperform vote.
28.0% of DURECT shares are held by institutional investors. 4.3% of DURECT shares are held by company insiders. Comparatively, 58.7% of Qilian International Holding Group shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.
Qilian International Holding Group has higher revenue and earnings than DURECT.
In the previous week, Qilian International Holding Group had 1 more articles in the media than DURECT. MarketBeat recorded 2 mentions for Qilian International Holding Group and 1 mentions for DURECT. Qilian International Holding Group's average media sentiment score of 0.00 equaled DURECT'saverage media sentiment score.
Summary
Qilian International Holding Group beats DURECT on 9 of the 13 factors compared between the two stocks.
Get Qilian International Holding Group News Delivered to You Automatically
Sign up to receive the latest news and ratings for QLI and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding QLI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Qilian International Holding Group Competitors List
Related Companies and Tools
